Chemical formula: C₁₃H₁₀N₂O₄ Molecular mass: 258.23 g/mol PubChem compound: 5426
Thalidomide is indicated for:
Population group: only adults (18 years old or older)
Thalidomide in combination with melphalan and prednisone is indicated as first line treatment of patients with untreated multiple myeloma, aged ≥65 years or ineligible for high dose chemotherapy.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Thalidomide is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
